Read more: Recent acquisitions help Numinus bolster revenue 240 per cent year-over-year Read more: Numinus approved to study ayahuasca and San Pedro in Canada Robison is also an adjunct professor at the University of Utah and Brigham Young University.
Robison also led a pivotal intravenous ketamine study for treatment-resistant depression by Janssen, leading up to that company’s recent FDA-approval of Spravato. He is also the medical director for the eating disorders clinic Center for Change and previously coordinated a study on MDMA-assisted therapy for eating disorders, sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS). Robison was the Chief Medical Officer at Novamind and he is a board-certified psychiatrist and co-founder of the ketamine-assisted mental health clinics Cedar Psychiatry. Numinus also announced the appointments of Reid Robison as Chief Clinical Officer and Paul Thielking as Chief Science Officer, who both come from Novamind. Read more: Numinus gets new biosecurity licence to expand psilocybin research The new leadership team has been announced Read more: Numinus to enter US psychedelics market via $26.2M Novamind acquisition Numinus stock went down by 4.3 per cent on Tuesday to $0.34 on the Toronto Securities Exchange. Last April, Numinus announced it entered into an agreement to acquire all of the issued and outstanding common shares of Novamind for $26.2 million. This acquisition expands the company’s services, geographic reach and revenues including the expansion of virtual therapy services at U.S.-based clinics and increased group therapy offerings in Canada. has been completed and received a final order from the British Columbia Supreme Court.Īs a result of the acquisition, Numinus now operates 13 wellness clinics, four clinical research facilities and a dedicated psychedelics research lab.
On Friday, the psychedelics company said the transaction to acquire Novamind Inc. (TSX: NUMI) (OTCQX: NUMIF) has officially entered the American psychedelics-assisted therapy market and announced its new leadership team.
0 kommentar(er)
